Download presentation
Presentation is loading. Please wait.
Published bySwen Hermann Modified over 5 years ago
1
A, Natalizumab blocks the adhesion of leukocytes to endothelial cells by blocking the interaction of the α4-integrin subunit of α4β1 with VCAM-1 and of α4β7 with mucosal MAdCAM-1. A, Natalizumab blocks the adhesion of leukocytes to endothelial cells by blocking the interaction of the α4-integrin subunit of α4β1 with VCAM-1 and of α4β7 with mucosal MAdCAM-1. B, This prevents autoreactive leukocytes from exiting blood vessels and entering target organs to cause inflammation. D.T. Selewski et al. AJNR Am J Neuroradiol 2010;31: ©2010 by American Society of Neuroradiology
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.